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 1 
ABSTRACT 
 
A series of hydrophobic and hydrophilic self-assembled monolayers (SAMs) were 
deposited by the adsorption of 1-dodecanethiol (SAM I), 11-mercapto-1-undecanol 
(SAM II), 16-mercaptohexadecanoic acid (SAM III), 5-(10-mercaptodecyloxy)benzene-
1,3-dioic acid (SAM IV) and 4-(10-mercaptodecyloxy)-pyridine-2,6-dicarboxylic acid 
(SAM V) on gold substrates. Crystallization experiments were carried out on SAMs I-V, 
on control surfaces (bulk gold, glass and PDMS (polydimethlysiloxane)) and in 
microfluidic devices to screen the polymorphs of two well known drugs, acetaminophen 
and barbital. Microfluidic devices consist of PDMS (polydimethlysiloxane) patterned 
with microchannels and then bonded to self-assembled monolayers (SAMs) of organic 
molecules on gold substrates. The crystallization of acetaminophen was carried out under 
thermodynamic conditions from solutions at room temperature and under kinetic 
conditions by rapid cooling. The results of crystallization experiments and the influence 
of self-assembled monolayers (SAMs) in controlling polymorphism by acting as 
nucleation sites, or templates, are discussed. 
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1. INTRODUCTION 
 
 The design and preparation of crystalline materials with desired properties is one of 
the principal aims for chemists. The existence of polymorphic forms of molecular solids 
offers a special chance for examining structure-property relationships because the main 
difference between polymorphs arises from variation in molecular packing arrangements 
within crystals rather than differences in molecular structure. Crystallization of drug 
molecules from solution as polymorphs—that is, different crystal forms in which the 
molecules adopt alternate packing arrangements—remains a persistent problem for 
crystal engineering.1,2 Polymorphism is particularly problematic in the development of 
pharmaceuticals because polymorphs of a single compound legally are classified as 
different drugs. Consequently, there is a need to develop methods to screen for the 
incidence of polymorphs and control which polymorphs form. Control over the 
polymorphic behavior of drugs, identification of different polymorphic forms of drugs 
and prediction of new polymorphs are major hurdles in the development and marketing 
of all pharmaceuticals that form crystalline solids.  In the pharmaceutical industry, 70% 
of barbiturates, 60% of sulfonamides and 23% of steroids exist in different polymorphic 
forms. Polymorph screening is an especially important part in the development of drugs 
because polymorphs impact the process at many levels that include patent protection, 
polymorph identification and characterization,3 development and process control to 
achieve consistent crystallization results.4 
While considerable effort has been spent investigating how factors such as 
concentration, temperature, solvent and pH influence nucleation and growth of 
polymorphs, considerably less is known about the influence of thin molecular films such 
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as self-assembled monolayers (SAMs) in this regard. While crystallization of inorganic 
minerals,5-11 organic compounds12-16 and proteins17,18 on SAMs, langmuir layers and 
other substrates have been reported, few studies have focused on the use of SAMs in 
controlling the incidence of polymorphs.19,20 Fewer studies still have focused on the use 
of microfluidic devices to carry out crystallization on small quantities of solution (e.g., 
nanoliters) in microchannels,21,22 although control of polymorphism has been studied in 
micropores and capillaries recently.23-25 In our research, we have focused on the questions 
of whether nucleation and growth of polymorphs of pharmaceuticals such as barbital 
(5,5’-diethylbarbituric acid) and acetaminophen can be promoted and controlled on 
SAMs on gold substrates both on bulk surfaces and in microchannels. We have begun to 
investigate microfluidic devices that contain multiple channels as a means to develop 
high throughput methods to screen for polymorphism.26 Goals of this research included 
determining (1) whether crystals of barbital and acetaminophen will nucleate on SAMs of 
gold substrates and in microchannels, (2) if nucleation of polymorphs occurs 
preferentially in microchannels on surfaces functionalized with a range of hydrophobic 
and hydrophilic organic groups, (3) whether the incidence of specific polymorphs–
particularly those that are less stable–can be controlled on different SAMs on bulk 
surfaces and in microchannels, and (4) whether microfluidic devices with multiple 
channels can be used to screen for polymorphs.  
 
Our strategy was to crystallize barbital and acetaminophen on a series of SAMs that 
contain nonpolar and polar groups exposed at the surface. We anticipated that assembly 
of barbital and acetaminophen molecules onto the surface of different SAMs via 
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hydrogen bonding might generate molecular aggregates that would serve as nucleation 
sites, or templates, that lead to different polymorphs during crystallization. 
 
2. Polymorphism 
2.1 What is polymorphism? 
Polymorphism is the ability of a substance to exist in two or more crystalline phases, 
or polymorphs, that have different arrangements and/or conformations of molecules in 
the solid state.1 Although the molecules in polymorphs have identical structure and 
properties in the solution phase, the physical properties of polymorphs generally differ, 
often quite dramatically. Different crystal modifications or crystal structures of the same 
molecule are referred to as polymorphs or forms. The stabilities of polymorphs, 
especially those that appear together, or concomitantly, generally are close with lattice 
energies that differ by no more than approximately 5 kcal/mol. One polymorph is the 
thermodynamically most stable form at any specific temperature except at temperatures 
where two polymorphs are in equilibrium. As the difference in lattice energy between 
two polymorphs becomes greater, the less stable polymorph is more likely to undergo a 
phase transformation either converting into the more stable form or a new form with 
greater stability. W. C. McCrone established in 1965 that polymorphic phase 
transformations of one crystalline form into a different crystalline form can occur 
exclusively in the solid phase without the solid first melting.27  
Polymorphism has been studied with a variety of commercially important materials 
ranging from silica, alumina, and metals to complex molecular compounds such as drugs, 
dyes, and plastics.27 Polymorphism is particularly problematic in the pharmaceutical 
industry because polymorphs of drugs differ in their physical properties (e.g., melting 
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point, solubility, and bioavailability). An important consequence of this variability is that 
all polymorphs of a given pharmaceutical compound legally are regarded as different 
drugs. As such, pharmaceutical companies spend considerable expense and effort to 
identify and patent as many polymorphs as possible. For example, the anti-ulcer drug 
Zantac (ranitidine hydrochloride) is a histamine receptor antagonist that works by 
decreasing the amount of acid produced in the stomach. Zantac has two known 
polymorphs that have been patented and sold commercially.28 Polymorphism in 
pharmaceutical solids, as in all molecular solids, is attributed to different packing 
arrangements that arise predominately based on differences in intermolecular interactions 
between molecules during crystal nucleation. Of all the different types of non-covalent 
interactions29-32 (i.e., hydrogen bonding, van der Waals interactions, ?-? stacking, 
electrostatic interactions, etc.) present in polymorphic solids, hydrogen bonding generally 
is the most important type of interaction because hydrogen bonds have the greatest 
strength and are directional.33  
The possibility of polymorphism exists for virtually any compound regardless of 
structure or size. The conditions necessary to obtain polymorphs, however, are not 
usually obvious. Often it is necessary to crystallize a compound under a broad range of 
conditions and then screen bulk samples of crystals in order to find polymorphs. Even 
when polymorphs are observed, it is difficult to know if additional polymorphs are 
accessible and under what conditions. McCrone adroitly explained the occurrence of 
polymorphism by stating: “It is at least this author’s opinion that every compound has 
different polymorphic forms and that, in general, the number of forms known for a given 
compound is proportional to the time and money spent in research on that compound.”27 
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 2.2 How does polymorphism occur? 
Figure 2.1 illustrates how polymorphism can result during the process of crystal 
nucleation or during a phase transformation from one crystal form to another. As shown 
on the right, two polymorphs result when molecules crystallize separately in two different 
conformations. Polymorphs that result from changes in molecular conformation are 
referred to as conformational polymorphs. For example, biphenyl is a well-known 
example of a compound that exhibits conformational polymorphism. In the stable form, 
the phenyl rings twisted about the central C-C bond 10°, while in the metastable form, the 
phenyl rings are coplanar.36 As shown on the left in Figure 2.1, polymorphs also result 
when molecules crystallize separately in different relative orientations or packing 
arrangements. For example, hexochloro-ketodihydrobenzene, C6Cl6O, is a 
conformationally rigid molecule that crystallizes in two different polymorphic forms.37 
The two forms differ in that the molecules pack in two different arrangements. In this 
case, the two polymorphs crystallize concomitantly under the same conditions, which 
indicate that the two polymorphs have similar lattice energy and, therefore, stability.  
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Figure 2.1 Polymorphism in molecular crystals arises when molecules pack in different 
conformations (right) or in different orientations (left). 
 
2.3 Stability of polymorphs 
Polymorphic phase transformations can occur when the difference in lattice energy 
between a metastable form and a more stable form is greater than several kcal/mol. Phase 
transformations can occur spontaneously in solution or in air. In many cases, external 
stimuli such as heating or mechanical grinding are required, however, to induce 
polymorphic transformation in order to provide enough activation energy to initiate 
molecular rearrangement in the solid. For example, the metastable form of biphenyl 
undergoes a polymorphic transformation to the stable form upon cooling. Competition 
between conjugation of double bonds in the two rings and the steric repulsion of the 
ortho-hydrogen atoms causes biphenyl to crystallize in the stable form with the phenyl 
rings twisted and in the metastable form with the phenyl rings coplanar. In crystals, the 
twisted and planar conformations are in equilibrium with the twisted form being more 
Orientational 
Polymorphism 
Conformational 
Polymorphism 
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stable then the planar form by about 1.5 kcal mol-1.36 The energy of a given polymorph is 
related to the Gibbs free energy. Lattice energy usually is taken as an estimate for Gibbs 
free energy. The relative stability of the two polymorphs depends on their free energies 
(lattice energies) with the more stable polymorph having the lowest lattice energy. The 
differences in free energies of different polymorphs might be very small (1-2 kcal mol-1). 
If two or more polymorphs have energetically equivalent structures or structures that are 
within ~ 1 kcal/mol, the different crystal forms can and frequently do appear at the same 
time under identical conditions. Polymorphs that appear simultaneously are referred to as 
concomitant polymorphs.1 The concept of concomitant polymorphs is illustrated by the 
drug barbital (5,5’-diethylbarbituric acid) , which has three known polymorphs (forms I, 
II and IV) that form concomitantly when barbital is crystallized by slow evaporation from 
solutions in ethanol.65,71 Forms I and II of barbital are both stable in air under ambient 
conditions, while metastable form IV slowly transforms to form I over days or weeks on 
standing in air. 
 
2.4 Can Polymorphism be controlled? 
Crystallization is the name of the process when upwards of 1020 molecules or ions 
spread essentially randomly throughout a fluid medium coalesce and naturally form a 
solid with a well-defined structure.1 How crystallization begins and how it proceeds are 
questions that are not completely understood. Models for crystallization have been 
developed to explain the different stages leading to the formation of molecular crystals.68-
70 The first stage of crystallization is known as nucleation. Nucleation occurs when 
molecules in solution aggregate, typically on a surface, to form a nucleus consisting of an 
ordered arrangement of molecules that serves as a site in the crystallization medium from 
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which crystals may grow. It is important to note that the packing arrangement of 
molecules in bulk crystals is defined by the arrangement of molecules present in a 
nucleus. Thus, a nucleus can be considered as an ordered aggregate, or template, 
containing the minimum number of molecules necessary to define the crystal structure. 
The number of molecules in a stable crystal nucleus differs depending on the structure 
and size of the molecule and typically ranges from 10 to 1000.71,72 Once a nucleus forms, 
growth occurs by subsequent addition of molecules from solution to propagate the 
arrangement of molecules present in the nucleus. Growth is a dynamic process in which 
molecules come into contact and bind to the surface of a growing nucleus. Under typical 
equilibrium conditions, molecules can remain bound or leave from the surface. For 
growth to occur, molecules must interact with other molecules on the surface in the 
appropriate orientation to maximize energetically favorable interactions (e.g., van der 
Waals interactions, hydrogen bonds, etc.) that prevent molecules from leaving the 
surface. In particular, hydrogen bonds frequently play an important role during nucleation 
because they are the strongest and most directional of all intermolecular interactions.7 
The selectivity of different organic functional groups in forming specific hydrogen-
bonding motifs (e.g., dimers between carboxylic acids) often results in specific 
aggregates that lead to different polymorphs. In some cases, hydrogen bonding leads to 
supramolecular aggregates with identical hydrogen bonding that form polymorphs by 
crystallizing in different arrangements.38 
The incidence of polymorphism can be attributed directly to the formation of 
molecular aggregates with different structures that lead to stable nuclei with different 
packing arrangements. Thus, each different stable aggregate that forms in solution has the 
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potential to serve as a nucleus for a unique polymorphic form. This concept is illustrated 
in Figure 2.2. Formation of different molecular aggregates generally occurs in response to 
competition between kinetic and thermodynamic factors during crystallization. Consider 
the hypothetical crystallization shown in Figure 2.2 in which two different aggregates 
promote nucleation and growth of four polymorphic forms, I-IV, where form I is the most 
stable and form IV is the least stable. Under thermodynamic conditions, the polymorph 
that is most stable (form I) will predominate regardless of the rate at which aggregates 1 
and 2 form; whereas, under kinetic conditions, the predominant polymorph or 
polymorphs will be determined by the aggregate that forms at the fastest rate. For 
example, even if form 1 is the thermodynamically most stable polymorph, forms 3 and/or 
4 will be the only polymorphs obtained if aggregate 2 nucleates crystal growth faster than 
aggregate 1. Any change that shifts the balance between thermodynamics and kinetics 
even slightly can have a significant impact on the polymorphs that appear. Consequently, 
the most common strategy to obtain new polymorphs or alter the distribution of 
polymorphs is to vary the conditions of crystallization (e.g., solvent, temperature, 
concentration, method of crystallization, etc.). 
 
                       
Molecules
Aggregate 1
Aggregate 2
Polymorphic form 1
Polymorphic form 2
Polymorphic form 3
Polymorphic form 4  
Figure 2.2 Model for crystallization of polymorphs. 
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Previous studies have established that factors such as solvent, temperature, 
concentration, pH and surfaces in contact with growth solutions influence nucleation and 
growth of crystals.4,39-41 The influence of each of these factors is summarized below. 
 
i. Solvent: It is generally accepted that solvents influence crystallization by 
preferential adsorption onto the different surfaces or facets of crystals as they develop 
thus hindering the deposition of solute molecules differentially on the different 
surfaces.73,75 For polar crystals, the effect of different solvents on crystal morphology can 
be observed easily. The variation in the rate of growth of two opposite faces that lie along 
the same polar direction is considered to result from solvent effects. For example the 
(010) face of N-n-octyl-D-gluconamide when exposed to polar solvents (e.g., methanol) 
grows about five times slower than the (010) face under the same conditions.76 Growth 
kinetics of N-n-octyl-D-gluconamide in a polar solvent fully support that the slowest 
growing face is indeed the more hydrophilic one. Different solvent systems also can lead 
to the appearance of different polymorphs. For example, 2,6-dihydroxybenzoic (DHB) 
acid has two known polymorphs, forms 1 and 2.78,79 These two forms contain different 
arrangements of molecules that arise from two different hydrogen bonding motifs. Form 
1 features discrete carboxylic acid dimers that are packed in a herringbone motif, while 
form 2 contains infinite hydrogen-bonded chains of carboxylic acids. It has been shown 
that dimerization in toluene solutions is the most effective means of maximizing the 
solute-solute interactions while minimizing the unfavorable polar-nonpolar interactions 
between toluene and DHB. In the presence of chloroform, however, formation of 
carboxylic acid dimers is hindered sterically due to the interaction of chloroform with the 
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carboxylic acid groups. It has been proposed that dimers do not form under those 
conditions because dimers would not be solvated effectively due to the unfavorable 
proton contacts as molecules of chloroform seek to maximize the number of favorable 
Cl...H-O interactions.80 
     
ii. Temperature: Temperature often controls nucleation and crystal growth by 
manipulating the solubility and supersaturation of the sample.43-45 Slow cooling often is 
used for saturated solutions if the compound is more soluble at high temperature. 
Alternatively, slow warming can be used if the compound is less soluble at higher 
temperatures. Slow cooling or warming allows the thermodynamically most stable 
polymorph to form under conditions where the selectivity is highest for nucleation and 
growth of that most stable form. In contrast, rapid cooling frequently leads to nucleation 
and growth of several different polymorphs, particularly when the solubilities of the 
different polymorphs are close. In general slow crystallization under thermodynamic 
condition gives larger crystals than fast crystallization under kinetic conditions. 
 
iii. Concentration: The time it takes for crystals to nucleate and begin growth 
depends on the concentration and the rate at which solvent evaporates. To reach the 
supersaturation point for a given solution to initiate crystallization requires either that the 
amount of solvent be reduced (e.g., evaporation of solvent) or that the solubility of the 
solute be reduced. Accordingly, evaporation of solvent is one of the more commonly 
used methods for crystallizing compounds. Ostwald demonstrated that unstable 
polymorphic forms have a greater solubility than the more stable forms in a particular 
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solvent.46 Therefore, crystallization by slow evaporation generally results in formation of 
the most stable polymorph.         
  
iv. pH: pH is another important factor that can affect crystallization and the 
appearance of polymorphs, especially for protein crystallization. In aqueous solution, a 
protein with hydrophilic groups on its surface is covered with surface-bond water 
molecules. Addition of ions to solution results in removal of some water molecules that 
leaves some sites on the surface of the protein free to bind to other protein molecules. 
Thus, aggregation of proteins and subsequent nucleation and growth of crystals often can 
be promoted simply by changing the pH of the solution.47 For example, glycine 
molecules pack as zwitterions in each of its three polymorphic forms (?, ? and ? glycine). 
Accordingly, the charge of glycine molecules will change depending on the pH range of 
the solution. It has been reported that glycine crystallizes in the ? form by forming 
centrosymmetric dimers in solutions with pH values between 3.8 and 8.9.35 Outside of 
this range, singly charged glycine molecules do not form dimers, but instead crystallize 
by forming polar chains that give the ? form of glycine.35       
    
v. Surface: Once a nucleus forms, growth units (atoms, ions or molecules) can 
diffuse from solution to the surface of the nucleus and incorporate into the lattice 
resulting in crystal growth.81 Adsorption of the growth units on the surface of a growing 
crystal may occur at three possible sites: 1) ledge sites having only one surface in contact 
with the growth unit, 2) step sites having two surfaces in contact, or 3) kink sites having 
three sites in contact. Because growth units with the greatest number of contacts are 
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bound most strongly to the surface, a kink site is the most favorable energetically. Thus, 
substrates that promote molecular aggregation and nucleation of crystals frequently have 
high energy three-dimentional surfaces that feature many kink sites. For example, 
formation of snowflakes as a result of nucleation of ice crystals on the high energy 
surface of dust particles is a well known example from nature of this principle. Similarly, 
scratching the bottom of a glass beaker with a glass rod to induce crystallization and 
distribute the resulting crystal nuclei throughout solution is a well established method for 
crystallization. The composition and structure of substrates on which nucleation occurs 
play an important role in directing selectivity toward different polymorphs. Such 
selectivity suggests that the availability of hydrogen-bonding functionality at the 
nucleation interface plays an important rule.3  
Many studies have been carried out examining the effect of temperature and solvents 
on polymorphism. Far fewer studies have examined the influence of surfaces and 
modication of the chemical functionality presented at surfaces as a means to control 
polymorphism. Several studies have shown that soluble “tailor-made” small-molecule 
additives or polymeric additives, single crystals, Langmuir monolayers and self-
assembled monolayers (SAMs) can behave as nucleation sites or templates that promote 
nucleation and growth of molecular crystals.5-12,14-17,48-57  
Self-Assembled Monolayers (SAMs) are ordered assemblies of molecules the 
thickness of a single molecule formed by adsorption of molecules from solution or a gas 
onto a solid surface. The molecules in SAMs are highly ordered and oriented and can 
incorporate a wide range of groups both in the alkyl chain and at the chain termini. The 
ability to tailor both head and tail groups of the constituent molecules makes SAMs ideal 
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systems to understand competition between intermolecular, molecular-substrate and 
molecule-solvent interactions. Surfaces other than SAMs also have been shown to induce 
oriented growth of crystals, but crystallization could not be controlled easily because the 
structures of these surfaces were neither homogenous nor well-defined.34,171-179  
Crystallization of inorganic compounds have been especially well studied on SAMs.5-
11 Aizenberg and Whitesides showed that using SAMs on metal surfaces as substrates for 
crystallization of calcite makes it possible to obtain a high level of control over crystal 
orientations.10 Swift, Varney and Hiremath showed the ability to influence nucleation and 
oriented growth of polar crystals of 4-iodo-4-nitrobiphenyl on SAMs with different 
functionalities.57 Studies focusing on crystallization of organic compounds on SAMs also 
have been reported.14 For example, crystallization of malonic acid on SAMs terminated 
with carboxylic acids, esters, and alkyl groups.14 That study demonstrated that the rate of 
at which crystals of malonic acid nucleate increased on SAMs with hydrogen-bonding 
functionality provided by terminal carboxylic acid groups when compared to other 
surfaces.  
Recently a study was carried out to examine the effect of solids of polymers in 
influencing heterogeneous nucleation of polymorphs of acetaminophen and other drug 
molecules.51 The important findings of that study were that crystallization of 
acetaminophen in the presence of different polymer solids resulted in the formation of 
form I or form II or a mixture of forms I and II of acetaminophen. Although the authors 
were not able to predict a priori which polymorphs would nucleate on given solid 
polymer, the polymorphs that formed did so reproducibly. This work demonstrated that it 
is possible to use heterogeneous nucleation on solids with different surface energies to 
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promote formation of different polymorphs of acetaminophen. More importantly, that 
work established that heterogeneous nucleation on polymer solids can be used to obtain 
the less stable form of acetaminophen. This study in particular provided  much of impetus 
for our work investigating the influence of SAMs as templates for controlling nucleation 
of polymorphs. 
 
2.5 Model systems for studying nucleation and growth of polymorphs of 
pharmaceuticals on surfaces 
For the purposes of this study, we sought two different polymorphic drug systems 
with the following requirements: (1) at least two polymorphs are known to be stable at 
room temperature; (2) the molecular structures have two or more functional groups 
capable of hydrogen bonding; (3) the compound is soluble both in organic solvents and 
water; and (4) the polymorphic forms can be distinguished both visually and 
spectroscopically. In addition, we wanted to find one system with concomitant 
polymorphs having similar lattice energies and stabilities. Our reasoning was that such 
systems would be useful in probing the effect of subtle variations in the interaction 
energies on different surfaces in controlling nucleation. By choosing polymorphs with 
similar lattice energies, we hoped to demonstrate that selectivity for one polymorph over 
another results predominantly from surfaces acting as templates for nucleation, rather 
from inherent differences in the stabilities of the polymorphs. For the second system, we 
tried to find a drug with stable polymorphs that do not form concomitantly in order to 
study the selectivity of surfaces in promoting nucleation of less stable or even metastable 
polymorphs. 
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 A survey reported in 199958 found 321 polymorphic systems in the Cambridge 
Structural Database of which 291 were dimorphic, 27 trimorphic, 3 had four polymorphs, 
and none had five or more. Many more examples of polymorphic systems are known, 
however, where the crystal structure of only one polymorph has been reported. 
Substituted barbituric acids are the one of the more extensively studied families of 
compounds that exhibit polymorphism extensively.59-64 For our research we selected to 
investigate barbital (5,5-diethylbarbituric acid), which has three known polymorphs 
(forms I, II and IV),65 and acetaminophen, which has two known polymorphs (forms I 
and II) that have been studied broadly.66-70  
 
2.5.1 Barbital (5,5-diethylbarbituric acid) 
We identified the family of drugs known as barbituric acids as a good source for 
polymorphs and chose barbital in particular as a model system for this study. The 
structure of barbital is shown in Figure 2.3. Our choice was based on previous work in 
which we established that barbituric acids are prone to polymorphism because the 
arrangement of amide groups in barbituric acids give these compounds considerable 
variability in their hydrogen-bonding associations.72 The presence of two N-H donors and 
three carbonyl acceptors introduces the potential for variability in the hydrogen-bonding 
motifs based on hydrogen-bonded dimers. For example, shown in Figure 2.4 are ten 
possible barbituric acid dimer configurations consisting of different centrosymmetric and 
noncentrosymmetric configurations that can form when substituents R1 and R2 are 
different. Considering that the energies of the hydrogen bonds in each dimer are similar, 
and that each dimer has additional sites at either end to form additional amide-amide 
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hydrogen bonds, it is not surprising that barbituric acids form a variety of different 
hydrogen-bonding motifs that frequently lead to different polymorphs during 
crystallization. To emphasize this point, shown in Figure 2.5 are six different hydrogen-
bonding motifs present in twenty-three crystal structures of barbituric acids from the 
Cambridge Structural Database that we reported previously.72 The molecules of 
barbituric acids formed two tape motifs (I and II), two ribbon motifs (I and II), and two 
layer motifs (I and II).  Of those, tapes were the most common motif, occurring in fifteen 
structures. 
 
                                                            
Figure 2.3 Structure of barbital (5,5-diethylbarbituric acid). 
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Figure 2.5 Hydrogen-bonding motifs observed in the crystals structures of barbituric 
acids.  X represents an O or S atom and L represents a range of organic substituent 
groups. 
 
Several studies of polymorphism in substituted barbituric acids have been 
reported.150-154 In one study, Cleverley and Williams examined twenty different barbituric 
and thiobarbituric acids by X-ray powder diffraction (XPD) and solid-state IR and found 
that nine of these barbituric acids exhibited polymorphism.155 In the case of 5-ethyl-5-
phenyl barbituric acid, six different polymorphs were observed to form by XPD. No 
correlation between molecular structure and the occurrence of polymorphism has been 
found for these compounds. 
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Craven reported previously that single crystals of three polymorphs of barbital—
referred to as forms I, II, and IV—were obtained from the same ethanolic solution.65,71 
Not surprisingly, the crystal structures of forms I, II, and IV show that molecules of 
barbital form three different hydrogen-bonding motifs. Craven concluded that barbital I, 
which has the highest melting point of the three compounds (range 190 ° to 176 °C), is 
the most stable structure because of more effective van der Waals contacts. The fact that 
all three crystalline forms were obtained concomitantly under the same crystallization 
conditions suggests the hydrogen-bonded aggregates in these structures are close in 
energy. 
In summary, we chose to to study barbital for the following reasons: 
• Barbital has three known polymorphs (forms I, II and IV) that can form 
concomitantly. 
• The polymorphs of barbital are stable enough to form and persist without 
undergoing rapid phase transformation. 
• The crystal structures of all three polymorphs are known.65,71 
• Barbital is soluble in solvents suitable for crystallizing on bulk SAMs and in 
microchannels. 
• Barbital has hydrogen-bonding groups complementary to functional groups 
terminating SAMs that we studied. 
Table 2.1 shows the melting point, crystal system and habit of each form. Figures 2.6, 
2.7 and 2.8 show examples of crystals and hydrogen-bonding motifs of each form. 
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Table 2.1 Melting point, crystal system and shape of forms for barbital. 
Form I II IV 
Melting Point 190 0C 183 0C 176 0C 
Crystal System Trigonal Monoclinic Monoclinic 
Habit Rhombohedral 
needles 
Prisms Twinned rectangular 
plates or flat 
pyramids 
 
Form I: 
 
       
 
 
 
                                      
Figure 2.6 Structure of form I of barbital (a) and the hydrogen-bonding motif of form I (a 
linear ribbon) illustrated with a ChemDraw diagram (b) and crystal packing diagram (c). 
 
 
(a) 
(b) (c) 
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Form II: 
                                            
       
Figure 2.7 Structure of form II of barbital (a) and the hydrogen-bonding motif of form II 
(a linear tape) illustrated with a ChemDraw diagram (b) and crystal packing diagram (c). 
 
Form III: 
       
 
 
(a) 
(b) (c) 
(a) 
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Figure 2.8 Structure of form IV of barbital and the hydrogen-bonding motif of form IV 
(a sheet) illustrated with a ChemDraw diagram (b) and crystal packing diagram (c).  
 
2.5.2 Acetaminophen 
In addition to barbital, we identified acetaminophen as a model system for this study. 
The structure of acetaminophen is shown in Figure 2.9. We chose acetaminophen in large 
part based on the study described earlier by Metzger that showed that nucleation and 
growth of the two polymorphs of acetaminophen (forms I and II) could be controlled by 
crystallizing acetaminophen in the presence of different polymeric solids.51 The presence 
of N-H and O-H donors and C=O and OH acceptors on acetaminophen introduces the 
potential for variability in the hydrogen-bonding motifs that result from different 
combinations of those functional groups as donors and acceptors. 
 
                                     
Figure 2.9 Structure of acetaminophen. 
 
 
(b) (c) 
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We chose to use acetaminophen because: 
• Acetaminophen has two known polymorphs. 
• The polymorphs of acetaminophen are stable enough to form and persist 
without undergoing rapid phase transformation. 
• The crystal structures of forms I and II of acetaminophen are known.68,69 
• Acetaminophen is soluble in solvents suitable for crystallizing on bulk SAMs 
and in microchannels. 
• Acetaminophen has hydrogen-bonding groups complementary to functional 
groups terminating SAMs that we studied. 
 
Table 2.2 shows the melting point, crystal system and habit of the two forms of 
acetaminophen. Figures 2.10 and 2.11 show examples of crystals and hydrogen-bonding 
motifs of each form. 
 
Table 2.2 Melting point, crystal system and shape of forms for acetaminophen. 
Form I II 
Melting Point 171-172 0C 160-161 0C 
Crystal System Monoclinic Orthorhombic 
Habit (shape) Block Prism 
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Form I: 
                                                      
                                      
Figure 2.10 Structure of form I of acetaminophen and the hydrogen-bonding motif of 
form I illustrated with a ChemDraw diagram (b) and crystal packing diagram (c).76 
 
Form II: 
                                                      
(a) 
(c) (b) 
(a) 
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Figure 2.11 Structure of form II 76 of acetaminophen and the hydrogen-bonding motif of 
form II (a sheet) illustrated with a ChemDraw diagram (b) and crystal packing diagram 
(c). 
 
3. Self-Assembled Monolayers 
3.1 Introduction and background on self-assembled monolayers 
Self-assembled monolayers (SAMs) are ordered assemblies of molecules the 
thickness of a single molecule formed by adsorption of molecules from solution or a gas 
onto a solid surface. In recent years, the field of SAMs has witnessed fantastic growth in 
the development of synthetic procedures to prepare SAMs, techniques to characterize 
surface structure, composition and properties of SAMs, and broad utilization of SAMs to 
chemical modify surfaces in biology, medicine, materials science, and manufacturing.77-87  
In 1946, Zisman published the first paper describing the preparation of a molecular 
monolayer by adsorption of a surfactant onto a clean metal surface.88 Initial development 
of SAMs focused in large part on using chlorosilane derivatives to hydrophobize glass 
substrates.77,89,90 More recently, efforts have focused predominantly on SAMs composed 
of substituted alkanethiolates on gold and other precious metals.91-109 Gold is the 
(b) (c) 
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substrate used most commonly because it does not oxidize easily in air. Oxidation of the 
metal surface generally interferes with deposition of SAMs and results in poor coverage. 
SAMs of substituted alkanethiolates on gold are prepared by adsorption of the 
corresponding alkanethiols or the di-n-alkyl disulfides from dilute solutions.110 SAMs 
continue to present exclusive opportunities to modify the properties of surfaces in order 
to investigate self-organization, structure-property relationships and interfacial 
phenomena. The ability to tailor both head and tail groups of the constituent molecules 
makes SAMs excellent systems to understand molecule-substrate, molecule-solvent and 
intermolecular interactions.78,111 SAMs are highly ordered and oriented and can include 
different groups both within the alkyl chain and at the chain termini. SAMs can be used 
for corrosion prevention, wear protection and similar applications because of their dense 
and stable structure.87,112-117 
SAMs also have been reported to serve as substrates that promote nucleation and 
growth of organic,14,56,57 inorganic,10 and protein crystals.16,17 For example, SAMs with 
different  chemical functional groups (e.g., carboxylic acids)  influence the heterogeneous 
nucleation and growth of crystals of malonic acid.14 Molecules of malonic acid crystallize 
by assembling into linear chains in which the molecules of malonic acid (HOOC-CH2-
COOH) are joined by hydrogen bonds between the acid groups on adjacent molecules. 
The carboxylic acid groups of malonic acid are exposed at the (001) facet, or plane, on 
the surface of crystals of malonic acid as they form. Crystallization of malonic acid from 
solution in the presence of SAMs composed of [Au]-S(CH2)11COOH resulted in oriented 
nucleation and growth of crystals. Growth occurred with the (001) facet of the crystals 
oriented parallel to the surface of the SAM with the COOH groups on the surface of the 
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crystal in contact with the COOH groups of the SAM.14 This study demonstrated that 
SAMs can serve as templates, or prenucleation sites, that influence aggregation of 
molecules from solution and subsequent nucleation and growth of crystals on those sites. 
An important finding of this work is that templated assembly of molecules and 
subsequent oriented nucleation and growth of crystals from solution onto a SAM requires 
hydrogen-bonding groups at the surface of the SAM that are complementary to those 
exposed on the surface of the crystal. In another study, SAMs of rigid biphenyl thiols 
were employed as heterogeneous templates for oriented crystallization of L-alanine and 
DL-valine.17 Hydrogen bonding between the functional groups exposed on the surface of 
the monolayer such as hydroxyl groups and carboxylate groups on molecules of alanine 
was observed as a driving force for oriented nucleation and growth of crystals of 
alanine.17 Whitesides also showed that face-selective nucleation of calcite occurred on 
SAMs of ?-terminated alkanethiols patterned  on the surface of gold and silver 
substrates.10 Oriented growth of calcite crystals occurred preferentially on SAMs 
terminated with hydrophilic CO2
-, SO3
-, PO3
2- and OH groups, while growth was 
inhibited on SAMs with hydrophobic N(CH3)3
+ and CH3 groups. These studies 
demonstrate that SAMs provide a convenient tool to control or at least influence 
nucleation and growth of molecular crystals by varying the geometry, chemistry and 
pattern of functional groups presented on the surface of SAMs. Moreover, these studies 
provide the foundation and, in part, the motivation for the research described in this 
thesis—namely, utilizing SAMs as prenucleation sites, or templates, to promote and 
control heterogeneous nucleation and growth of polymorphs of pharmaceuticals such as 
barbital and acetaminophen. 
 38
3.2 SAMs used for crystallization 
The different SAMs shown in Figure 3.1 were used for crystallization experiments 
with barbital and acetaminophen. All SAMs feature alkyl chains with ten or more 
methylene units because previous studies have shown that alkanethiols with ten or more 
carbon atoms pack more efficiently with greater order than alkanethiols with fewer than 
ten carbon atoms.118-121 Alkanethiols are known to self-assemble on the (111) surface of 
gold substrates in a hexagonal or pseudohexagonal arrangement in which the alkyl chains 
tilt over 30° from perpendicular to the surface.120,122,123 This commonly observed closest-
packed structure in alkanethiols on Au(111) is referred to as an )3x3(R30°  packing 
arrangement. We expect SAMs I-III to adopt the )3x3(R30° packing arrangement 
because those SAMs have small head groups that will not interfere with closest-packing 
of the alkyl chains.124-126 In the case of SAMs IV and V; the head groups are wider than 
the underlying alkyl chains. Therefore, it is not clear what packing arrangement those 
SAMs will adopt.  
 
 
16-Mercaptohexadecanoic 
acid 
(SAM III) 
5-(10-mercaptodecyloxy) 
benzene-1,3-dioic acid 
(SAM IV)  
11-Mercapto-
1-undecanol 
(SAM II) 
1-Dodecanethiol 
(SAM I) 
4-(10-mercaptodecyloxy) 
pyridine-2,6-dicarboxylic 
acid 
(SAM V) 
(a) 
(b) 
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Figure 3.1 (a) Chemical structures of SAMs I-V deposited on gold substrates for 
experiments. (b) Chemical structures used for control experiments. 
 
The head groups of SAMs I-V were selected to provide both hydrophobic and 
hydrophilic surfaces with a range of surface energies. SAM I has a hydrophobic methyl 
head group, while other SAMs have hydrophilic OH, COOH and pyridine head groups 
that are capable of forming hydrogen bonds. For example, the protic OH group on SAM 
II can serve both as a hydrogen-bonding donor and as an acceptor at the lone pairs of 
electron on the oxygen atom, The carboxyl group on SAM III also can donate and accept 
hydrogen bonds via the acidic OH group and the C=O group. SAMs IV and V both 
feature two carboxyl groups. In addition, SAM V has a basic pyridine group that serves 
as an additional site for accepting hydrogen bonds. We chose to utilize SAMs II-V 
specifically because those SAMs are terminated with hydrogen-bonding donor and 
acceptor groups that are complementary to those present on barbital and acetaminophen.  
As shown in Figure 3.2a, barbital features a total of and two N-H donors and three 
C=O acceptors. Both urea-type N-H donors and the two amide-type C=O acceptors of 
barbital are identical chemically because of two-fold symmetry within the molecule. The 
urea-type and amide-type C=O groups of barbital differ chemically. Acetaminophen 
contains a total of two donors and two acceptors. The O-H and N- H donors differ 
chemically as do the phenolic O-H and amide C=O acceptors of acetaminophen. Etter has 
established that chemically distinct organic hydrogen-bonding donors and acceptors 
generally show different hydrogen-bonding behavior with the strongest (most acidic) 
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donors and the strongest (most basic) acceptors selectively forming hydrogen bonds with 
each other.127 In the absence of other hydrogen-bonding groups, molecules of barbital and 
acetaminophen undergo homomeric (self) assembly that can lead to different motifs of 
hydrogen bonding depending on which donors and acceptors interact to form hydrogen 
bonds. For example, dimeric aggregates of barbital with three different motifs (i.e., forms 
I, II and IV) are shown in Figure 3.2b. In the presence of other competing hydrogen-
bonding groups, barbital and acetaminophen may undergo heteromeric rather than 
homomeric assembly to form hydrogen-bonded complexes when the best hydrogen-
bonding donor and acceptor reside on different types of molecules. For example, as 
shown in Figure 3.2c, barbital can undergo heteromeric assembly with carboxylic acids 
and alcohols because those groups have donors that are more acidic than the urea-type N-
H groups of barbital. Such heteromeric assembly can lead to complexes with several 
different structural motifs depending on which N-H and C=O groups of barbital are 
involved in hydrogen bonding. Acetaminophen similarly can undergo heteromeric 
assembly to form hydrogen-bonded complexes with carboxylic acids and alcohols that 
can adopt several different structural motifs.  
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Figure 3.2 a) Hydrogen-bonding donor and acceptor groups on barbital and 
acetaminophen. b) Examples of different hydrogen-bonding motifs that result from 
homomeric (self) assembly of barbital. c) Examples of different hydrogen-bonding motifs 
that can result from heteromeric assembly of barbital with carboxylic acids and alcohols. 
 
We chose to crystallize barbital and acetaminophen on SAMs with head groups that 
contain different arrangements of hydrophilic OH, COOH and pyridine functional groups 
to promote heteromeric assembly with barbital and acetaminophen through hydrogen 
bonding on the surface. Figure 3.3 illustrates heteromeric assembly of barbital on SAMs 
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terminated with carboxylic acid and alcohol groups. The orientation of barbital on the 
surface of each SAM depends on which C=O group participates in hydrogen bonding, 
whether the molecules form a single hydrogen bond or two hydrogen bonds with the 
functional groups on the surface, and the tilt-angle, orientation and order of the head 
groups of the SAMs. For example, assembly of barbital via a single hydrogen bond on 
SAM II results in two different orientations of barbital on the surface, as shown on the 
right in Figure 3.3. Hydrogen bonding via the urea-type C=O orients the molecule with 
the ethyl substituents exposed on the surface, while hydrogen bonding via the amide-type 
C=O orients the molecule with the hydrogen-bonding groups exposed on the surface. Our 
goal is investigate whether formation of aggregates such as those shown in Figure 3.3 can 
be controlled on different SAMs and to determine if such templates will influence 
subsequent nucleation and growth of different polymorphs. 
 
 
Figure 3.3. Illustration of different modes of hydrogen bonding interactions between 
barbital and SAMs terminated with COOH and OH groups. 
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3.3 Preparation of SAMs 
Organosulfur compounds such as alkanethiols, di-n-alkyl sulfide, di-n-alkyl 
disulfides, mercaptopyridines and mercaptoanilines have a strong affinity for the surfaces 
of transition metals.118,128-131 Of the SAM systems above, the most studied and best 
understood by far is that of alkanethiolates on Au surfaces. For alkanethiols, addition of 
the S-H bond to the gold surface may be considered as an oxidative addition according to 
the following equation.132 
 
 R-S-H + Aun
0
R-S
-
Au
+
.Au
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 + 
1
/
2
 H
2  
 
Although organosulfur compounds form SAMs by chemisorption on other substrates 
such as silver, copper, platinum, mercury, iron and GaAs, gold is the preferred substrate 
because it does not have a stable surface oxide.121 Moreover, its surface can be cleaned 
chemically with Piranha solution (70% H2SO4/30% H2O2) to remove physically and 
chemically adsorbed impurities. SAMs of alkanethiols on gold can be prepared readily as 
shown in Figure 3.4. The resulting SAMs of alkanethiols on gold generally form with 
high surface coverage and are highly ordered. 
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Figure 3.4 Preparation of  SAMs of alkanethiols on gold.  
 
Two different adsorption kinetics predominate during adsorption of alkanethiols onto 
Au(111) surfaces in dilute solutions (~ 1mM). The initial and fastest step of adsorption 
occurs within a few minutes. For example, previous reports have shown that, the 
thickness of SAMs reaches 80-90 % of the maximum value and that the contact angle of 
water droplets approaches the limiting values during the first few minutes.133 During the 
second and slower step, completion of adsorption takes several hours, at which time 
thickness and contact angle reach their maximum values. SAMs can be prepared from 
substituted alkanethiols as well as unsubstituted alkanethiols. It is important to note that 
several constraints apply, however, when SAMs are prepared from substituted 
alkanethiols with head groups containing reactive functional groups or dimensions larger 
than that of typical straight-chain alkanes. For example, the head group should not 
contain any chemical functionality that competes with the thiol in coordinating to gold. 
Second, the head group must not react with the thiol. Third, the head group must not be 
so sterically demanding as to cause poor packing of the underlying hydrocarbon chains. 
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3.3.1 Experimental procedures used to prepare SAMs on gold. 
Glass slides with dimensions of 3 in. x 1 in. x 0.4 in. coated with 50 Å of chromium 
followed by 1000 Å of gold (Evaporated Metal Films) were cut into 1 in. x 1 in. squares 
that were cleaned in piranha solution (70% H2SO4, 30% H2O2) for 10 min, rinsed with 
deionized water and ethanol, and dried under nitrogen. Monolayers of ?-substituted 
alkanethiols were prepared by immersing the clean gold slides in 2 mM ethanolic 
solutions of the desired compound for 24 h at room temperature. Commercially available 
?-substituted alkanethiols (i.e., 1-dodecanethiol, 11-mercapto-1-undecanol and 16-
mercaptohexadecanoic acid were purchased from Aldrich and used without further 
purification. 5-(10-mercaptodecyloxy)benzene-1,3-dioic acid and 4-(10-
mercaptodecyloxy)-pyridine-2,6-dicarboxylic acid were prepared using synthetic 
procedures we reported previously.134,135 1-Dodecanethiol (SAM I), 11-mercapto-1-
undecanol (SAM II), 16-mercaptohexadecanoic acid (SAM III), 5-(10-
mercaptodecyloxy)benzene-1,3-dioic acid (SAM IV) and 4-(10-mercaptodecyloxy)-
pyridine-2,6-dicarboxylic acid (SAM V) were deposited on gold substrates. The resulting 
SAMs on gold were rinsed with ethanol and dried with nitrogen just prior to being used 
for crystallization experiments.  
 
3.4 Characterization of SAMs 
3.4.1 Contact Angle Goniometry 
The phenomenon of wetting or non-wetting at the surface of a solid by a liquid 
reflects the hydrophobic or hydrophilic nature of the surface and provides valuable 
insight into the interaction energy at the surface. The technique of contact angle 
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goniometry provides a convenient means to quantify the wettability of surfaces by 
measuring the wetting angle, or contact angle, when of a sessile drop of water (or other 
liquid) is placed in contact with the surface. The contact angle is measured by placing a 1 
μL drop of water onto the surface and then measuring the angle between the plane 
tangent to the surface of the drop of water where it meets the surface and the plane 
tangent to the surface of the solid. The contact angle is measured by viewing the profile 
of the drop on the surface through a magnifying lens equipped with a goniometer. This 
concept is illustrated in Figure 3.5. 
 
 
 
 
   
Figure 3.5  Example of a contact angle measurement. 
Contact angles offer an easy-to-measure indication of the chemical bonding between 
functional groups exposed on the surface of the substrate and molecules of water in the 
drop. This bonding determines wettability and adhesion, and also allows prediction of 
coating properties and detection. Contact angles also provide information about surface 
energy and surface tension of the drop. For our purposes, contact angle is a suitable 
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method to measure the relative hydrophobic or hydrophilic character of SAMs with 
different head groups.136,137  
Contact angle measurements of SAMs I-V and bare gold were determined using a 
Rame-Hart Model 100-00 Goniometer (Mountain Lakes, NJ). Drops of water (1 μL) were 
deposited with a micropipette and viewed through a low-power microscope. The 
microscope produced a clear image of the profile of the sessile drops on each of the 
different substrates, as shown in Figure 3.6. The contact angles for SAMs I-V and bare 
gold are given in Table 3.1. The reported contact angles are the average of five 
independent readings. The contact angles we measured for SAM I, SAM II and SAM III 
were consistent with values reported previously in the literature.138 
 
 
Figure 3.6 Images of 1μL  drops of water on SAMs I-V and bare gold viewed through a 
microscope equipped with a goniometer: (a) SAM I; (b) SAM II; (c) SAM III; (d) SAM 
IV; (e) SAM V and (f) bare gold. 
 
 
 
(a) (b) (c) 
(d) (e) (f) 
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Table 3.1 Contact angle measurements of SAMs. 
Surface Contact angle (º) 
Bare Au 78.6 ± 0.9 
SAM I 113.8 ± 0.2 
SAM II 35.2 ± 0.4 
SAM III 42.9 ± 0.7 
SAM IV 69 ± 0.5 
SAM V 72.6 ± 0.5 
 
 
3.4.2 Ellipsometry 
Ellipsometry is a sensitive technique that uses polarized light to measure the thickness 
of thin films, surfaces, and microstructure of materials.110,139-141 Polarized light is shone 
onto the surface of a sample at an oblique angle of incidence. The plane of incidence of 
the light is the plane that contains both incident and reflected beams. The polarization of 
light reflected parallel (p) and perpendicular (s) to the plane of incidence is measured. 
This polarization allows the relative phase change (delta) and relative amplitude change 
(psi) from the reflected surface to be determined. These values are related to the thickness 
of the SAM with refractive index (k) and extinction coefficient (n).  
The thickness of SAMs I-V on the Au substrates was estimated using a Manual 
Photoelectric Rudolf 439L633P ellipsometer (Rudolph Instruments, Fairfield, NJ) (He-
Ne laser, ?=632.8 nm, angle of incidence 70°). Readings were taken on bare gold to 
establish the optical constants (refractive index, k and extinction coefficient n) which 
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were compared to values previously reported in literature.142 Four separate points were 
measured on each sample and the readings averaged using an assumed refractive index of 
1.47. The thicknesses of SAMs I-V are shown in Table 3.2. All values of thickness were 
determined using the software package 439PCS11 Ellipsometry Analysis (rev. 1.0) from 
Rudolph Instruments. 
 
Table 3.2 Thickness of SAMs. 
SAM Thickness (nm) 
SAM I 1.35 
 SAM II 1.5 
  SAM III 1.8 
 SAM IV 1.6 
SAM V 1.5 
 
 
3.4.3 Grazing angle FT-IR 
 
The ideal method to obtain FT-IR spectra of SAMs on gold is the grazing angle 
technique. This technique includes the reflection of incoming light under a large angle of 
incidence (greater than 80º) relative to the surface normal. This technique has been used 
widely to study and characterize the adsorption of molecules on metal 
surfaces.91,92,110,119,143,144 Grazing angle IR spectra are similar to IR spectra obtained using 
normal transmission techniques on bulk samples with one important difference; grazing 
angle IR spectra do not show all IR absorption bands expected for the compounds 
 50
because transition dipoles parallel to the surface generally are not observed. Grazing 
angle IR is a useful technique for our purpose of characterizing SAMs because 
characteristic absorption bands of the alkyl, alcohol and carboxylic acid functional groups 
present in the head groups of SAMs I-V are present and easily identified.  
FT-IR surface spectra were obtained with a Nexus FT-IR model 670 spectrometer 
equipped with a ThermoNicolet grazing angle accessory and a liquid-nitrogen cooled 
MCTA detector. The IR beam was incident at 75° on the gold substrates. The optical path 
was purged with N2 gas before and during the collecting data. For each sample 64 scans 
were collected with a 4 cm-1 resolution. The scan range was from 4000 to 400 cm-1 with 
the range from 4000-680 cm-1 giving the most useful information for the SAMs used in 
this research. A clean gold substrate was used to obtain a background spectrum before 
collecting the spectra on the different SAMs. Grazing angle IR spectra obtained from 
SAMs I-V are shown in Figure 3.7. 
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Figure 3.7. Grazing angle FT-IR spectra of SAMs that were used for crystallization 
experiments. (a) SAM I. (b) SAM IV. (c) SAM III. (d) SAM II. (e) SAM V. 
 
3.4.4 Cyclic Voltammetry 
Cyclic voltammetry (CV) is one of the most commonly used electrochemical 
techniques to investigate the surface coverage and order of SAMs by measuring the 
insulating behavior of well-packed monolayers.80,145-149 CV measurements are made 
based on a linear potential waveform obtained by changing the potential as a linear 
function of time. The electrode potential is ramped linearly to a more negative potential, 
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and then ramped in reverse back to the starting voltage. The forward scan produces a 
current peak for any analytes that can be reduced through the range of the potential scan. 
The current will increase as the potential reaches the reduction potential of the analyte, 
but then falls off as the concentration of the analyte is depleted close to the electrode 
surface. As the applied potential is reversed, it will reach a potential that will reoxidize 
the product formed in the first reduction reaction, and produce a current of reverse 
polarity from the forward scan. This oxidation peak will usually have a similar shape to 
the reduction peak. 
Cyclic voltammetry measurements were obtained using an EG&G Princeton Applied 
Research Potentiostat/Galvanostat Model 273. A platinum wire counter electrode, 
standard calomel reference electrode and SAM on gold as the working electrode were the 
electrodes used for measurements. The SAM coated gold substrate was connected with 
an alligator clamp and 1cm2 of gold substrate was kept immersed in solution. 
Experiments were done in 1mM potassium ferricyanide as the redox active species with 
0.1 M potassium chloride as a supporting electrolyte.  To reduce electrical noise, the 
electrochemical cell was placed inside a Faraday cage. The cyclic voltammetry curves 
were obtained generally in the range of -0.5 to +0.7 V with a scan rate of 50 mV/s and a 
scan increment of 1mV.  The cyclic voltammograms for SAMs I-V and bare gold are 
shown in Figure 3.8. The CV measurements show that the redox activity of Fe+2/Fe+3 
observed using bare gold as the working electrode went to zero when SAMs on gold were 
used as the working electrode. The absence of any redox activity of the ferricyanide 
mediator indicates that SAMs I-V cover the surface of the gold substrate uniformly with 
few defects.   
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Figure 3.8 Cyclic voltammograms of SAMs I-V and bare gold. 
 
4. Crystallization on SAMs 
4.1 Crystallization on SAMs on bulk surfaces 
Nucleation, which is the first step of crystallization, generally is affected by a number 
of factors that include free energy of a surface, temperature, degree of supersaturation, 
solubility and concentration.1,14,17,42,57,156-158 Changes to any one of these factors can alter 
the arrangement of molecules within aggregates and the structure of those aggregates on 
surfaces and in solution. Our hypothesis is that molecular aggregates that form on 
surfaces prior to nucleation will serve as prenucleation sites, or templates, that promote 
nucleation of crystals and influence the packing arrangement of molecules within nuclei 
as they form.  Accordingly, our goal is to test whether we can control the incidence of 
different polymorphs of barbital and acetaminophen by changing these parameters 
systematically using a range of conditions for crystallization. For example, parameters 
such as free energy of the surface can be altered using a series of SAMs with different 
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head groups, while degree of supersaturation, solubility and concentration can be 
changed by varying the temperature, the type of solvent used and rate at which solvent 
evaporates during crystallization. 
Accordingly, we employed three different methods to crystallize barbital and 
acetaminophen that we refer to as method 1, method 2 and method 3. Methods 1 and 2 
involved using slow evaporation of solvent at two different rates to achieve slow 
nucleation and growth of crystals under thermodynamic conditions. Method 3 involved 
using rapid cooling of a solution to drive crystallization by changing the degree of 
supersaturation and achieve fast nucleation and growth of crystals under kinetic 
conditions.  
 
Figure 4.1 (a) Crystallization set up for method 1 (solvent at the bottom of the Petri 
dish). (b) Method 2 (no solvent at the bottom of the Petri dish). (c) Method 3. 
(a) (b) 
(c) 
2 cm 2 cm 
1 cm 
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Each of the three methods was carried out with barbital using three different 
solvents—ethanol, water and ethyl acetate—to study the effects of changing polarity, 
solubility, rates of evaporation, the presence or absence of protic groups, and solvation of 
barbital, as well as the different SAMs, in controlling which polymorphs formed. The 
three solvents were chosen in part based on the requirement that barbital exhibit good 
solubility. We used ethanol and water because both are polar solvents with one or two 
protic OH groups capable of accepting and donating hydrogen bonds with protic donors 
and basic acceptors present on barbital as well as on the head groups of SAMs. Both 
ethanol and water were chosen because ethanol features both nonpolar hydrophobic and 
polar hydrophilic groups, while water features only polar hydrophilic groups. We used 
ethyl acetate as a representative polar aprotic solvent with no acidic groups capable of 
serving as hydrogen-bonding donors. Crystallization experiments with acetaminophen 
were carried out using only ethanol. The different solution concentrations of barbital and 
acetaminophen used are shown in Table 4.1. 
 
Table 4.1 Concentration of barbital and acetaminophen in solutions used for 
crystallization. 
Barbital 
Solvent Method 1 Method 2 Method 3 
Ethanol 0.35M 0.35M 0.7M 
Ethyl Acetate 0.1M 0.1M 0.15M 
Water - 0.036M 0.07M 
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Acetaminophen 
Solvent Method 1 Method 2 Method 3 
Ethanol 0.1M 0.1M 0.2M 
 
 
4.1.1 Method 1 
For method 1, the substrate was placed on a glass microscope slide that was 
suspended on plastic caps in Petri dish. Solvent was then added to the Petri dish until the 
level of solvent reached half way between the bottom of the dish and the substrate 
suspended above. Ten drops of the drug solution at room temperature were delivered by 
syringe to the surface of the substrate. The Petri dish was then covered with the lid of the 
Petri dish. This setup allowed the solvent to evaporate slowly over days from small gaps 
between the Petri dish and cover.  Excess solvent underneath the suspended substrate 
served to minimize the rate of evaporation by saturating the atmosphere inside the 
container with solvent vapor. Crystallization experiments were carried out on SAMs I-V 
and also on glass, gold and PDMS as control experiments for barbital. PDMS was not 
tested with acetaminophen because initial crystallization experiments in ethanol showed 
that acetaminophen was not a suitable choice for further study. We did not carry out 
crystallization experiments with acetaminophen in microchannels for the same reason. 
Five trials were carried out for each SAM and control surface. Crystallization from 
ethanol generally produced crystals in 1-2 days. Crystallization from ethyl acetate 
generally gave crystals in less than 24 hours. Water was not used for this method because 
of its low volatility. Whenever possible, samples of crystals were isolated from solution 
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prior to complete evaporation of all solvent to avoid possible contamination by crystals 
formed rapidly under kinetic conditions. 
 
4.1.2 Method 2 
The conditions used for method 2 were identical to those for method 1 except that 
no excess solvent was placed under the substrate. For method 2, the substrate was placed 
on a glass microscope slide that was suspended on plastic caps in Petri dish. Ten drops of 
the drug solution at room temperature were delivered by syringe to the surface of the 
substrate by syringe. The Petri dish was then covered with the lid of the Petri dish. This 
setup allowed the solvent to evaporate slowly over days from small gaps between the 
Petri dish and cover. Crystallization experiments were carried out on SAMs I-V and also 
on glass, gold and PDMS as control experiments for barbital. PDMS was not used for 
experiments with acetaminophen. Five trials were carried out for each SAM and control 
surface. Crystallization from ethanol generally produced crystals within 12 hours. 
Crystallization from ethyl acetate generally produced crystals within 1-2 hours. Water 
was not used for this method because of its low volatility. Whenever possible, samples of 
crystals were isolated from solution prior to complete evaporation of all solvent to avoid 
possible contamination by crystals formed rapidly under kinetic conditions.  
 
4.1.3 Method 3 
For method 3, the substrate was placed onto the surface of an aluminum block and 
cooled to 0 °C by circulating ice water through the block. The drug solution and syringe 
both were heated separately to 60 °C. It was necessary to heat the syringe prior to 
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introducing the drug solution to prevent crystallization inside of the syringe. Ten drops of 
the drug solution at 60 °C were delivered by syringe to the surface of the substrate. 
Crystallization experiments were carried out on SAMs I-V and also on glass and gold as 
control experiments for barbital. Cooling on an aluminum block could not be used in 
control experiments with PDMS as the substrate because of the insulating properties of 
PDMS. Accordingly, Method 3 was not used with PDMS as a substrate. Five trials were 
carried out for each SAM and control surface. Crystallization from all solvents generally 
produced crystals in less than 10 minutes. In all cases, samples of crystals were isolated 
from solution.  
 
4.2 Crystallization on SAMs in microfluidic channels 
Crystallization experiments also were carried out on SAMs in microfluidic channels. 
We have begun to investigate microfluidic devices that contain multiple channels 
composed of polydimethylsiloxane (PDMS) on SAMs as a means to develop high 
throughput methods to screen for polymorphs. Crystallization in microchannels offers 
several advantages over crystallization on bulk surfaces that include: (1) microchannels 
require very small quantities (micro or nanoliters) of solution for crystallization; (2) 
multiple channels can be used to carry out multiple crystallization experiments 
simultaneously on a single device; and (3) individual channels functionalized with 
different SAMs allow for crystallization experiments on a range of SAMs 
simultaneously. Two potential disadvantages of using microchannels instead of bulk 
surfaces are that methods involving slow evaporation cannot be used to drive 
crystallization because microchannels behave essentially as closed systems, and that 
characterization of different polymorphic forms can be difficult because microchannels 
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necessarily limit the size of crystals that can grow. The goals of this research include 
determining (1) if crystals of barbital will nucleate selectively on SAMs in 
microchannels, (2) whether nucleation of polymorphs occurs reproducibly in 
microchannels on surfaces functionalized with a range of hydrophobic and hydrophilic 
SAMs, (3) if PDMS in the walls of the channels competes with SAMs in promoting 
nucleation of polymorphs; (4) whether the incidence of specific polymorphs on SAMs in 
microchannels is similar to that on SAMs on bulk surfaces, and (5) whether microfluidic 
devices with multiple channels are practical as devices to grow crystals and to screen for 
polymorphs.  
 
4.2.1 Fabrication of microfluidic devices 
We chose to fabricate microfluidic devices using poly(dimethylsiloxane) (PDMS) 
because procedures to prepare and pattern microchannels are well established.159 PDMS 
is ideal as a material for attaching to SAMs and studying crystallization. For example, 
PDMS is nontoxic; it cures at low temperatures; it is elastomeric so it releases easily from 
delicate features of a mold without damaging the mold or itself; it bonds well to SAMs 
and other surfaces and also releases with little force from those same surfaces; it is 
transparent optically, which allows crystallization to be monitored using an optical 
stereomicroscope. 
Microfluidic devices in polydimethylsiloxane (PDMS) were prepared with a single 18 
mm x 1 mm x 0.2 mm channel or multiple 18 mm x 0.7 mm x 0.1 mm channels, as 
shown in Figure 4.2. 
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Figure 4.2 (a) Microfluidic device with a single channel (1 mm x 18 mm x 0.2 mm).       
(b) Microfluidic device with ten channels (0.7 mm x 18 mm x 0.1 mm). 
 
Microchannels were fabricated using an elastomeric PDMS kit (SYLGARD-184, 
Dow Corning) consisting of a vinyl-terminated silicone base polymer that was mixed 
with a methyl hydrosiloxane crosslinking agent (10:1 w/w) and a platinum catalyst. After 
mixing and removing air bubbles under vacuum, the mixture was poured onto a 
silicon/SU-8 master and cured at 60 °C overnight. The resulting slab of PDMS was 
removed from the master, frozen in liquid nitrogen, holes were drilled at either end 
perpendicular to the channels, and polyethylene tubes (Becton Dickinson) with an inner 
diameter of 0.86 mm and an outer diameter of 1.52 mm were inserted into channels. The 
PDMS was then washed with soapy water, rinsed thoroughly with deionized water, dried 
and placed onto SAM-coated gold substrates. A bead of Epoxy was placed along all 
edges of the PDMS. The Epoxy served to seal the ends of the open channels exposed on 
the edges of the PDMS, and also to hold the PDMS in place on the SAM. Although we 
found that PDMS often showed weak sealing properties when placed in contact with 
2.54 cm 
channel 
SAM on gold 
PDMS 
inlet 
outlet 
2.54 cm 
channel 
inlet 
epoxy 
PDMS 
outlet 
(a) (b) 
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SAMs on gold, adhesion of PDMS to the SAMs generally was strong enough to prevent 
leakage of solution from individual microchannels. 
 
  
Figure 4.3 Fabrication of microfluidic device and growth of crystals. 
4.2.2 Crystallization of barbital in microchannels 
Barbital was crystallized in microchannels placed on SAMS I-V and also on PDMS 
as a control. Five separate experiments were carried out on each of these substrates. 
 62
Crystals were grown from solutions in absolute ethanol using the two general methods 
described below. We carried out crystallization experiments with just barbital because 
experiments with acetaminophen on bulk surfaces coated with SAMs gave only form I of 
acetaminophen. The different solvents and concentrations of barbital used for 
microfluidic device experiments are shown in Table 4.2. 
 
Table 4.2 Concentration of barbital solutions used for crystallization in microfluidic 
devices. 
Solvent Method 1 Method 2 
Ethanol 0.35M 0.7M 
Water 0.036M 0.07M 
 
4.2.2.1 Method 1 
Solutions of barbital were injected into microchannels with a syringe, the tubes were 
sealed, and the solution was allowed to sit undisturbed at room temperature. Ethyl acetate 
was not used for crystallization experiments in microchannels because that solvent causes 
significant swelling of the PDMS elastomer. Crystallization experiments were carried out 
on SAMs I-V and also on glass, gold and PDMS as control experiments for barbital. Five 
trials were carried out for each SAM and control surface. Crystals appeared in the 
microchannels within 24 hours from solutions containing ethanol or water. 
4.2.2.2 Method 2 
For method 2, the microfluidic device was placed onto the surface of an aluminum 
block and cooled to 0 °C by circulating ice water through the block. Cooling on an 
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aluminum block could not be used in control experiments with PDMS as the substrate 
because of the insulating properties of PDMS. Accordingly, the microfluidic device was 
placed into a freezer at -5 °C when PDMS was used as a substrate. The drug solution and 
syringe both were heated to 60 °C. It was necessary to heat the syringe prior to 
introducing the drug solution to prevent crystallization inside of the syringe. Solutions of 
barbital at 60 °C were injected into microchannels in the microfluidic device. Ethyl 
acetate was not used for crystallization experiments in microchannels because that 
solvent causes significant swelling of the PDMS elastomer. Crystallization experiments 
were carried out on SAMs I-V and also on glass, gold and PDMS as control experiments 
for barbital. Five trials were carried out for each SAM and control surface. Crystals 
generally appeared within several minutes. Individual crystals were isolated for 
characterization by removing the PDMS slab from the substrate. 
 
4.3 Characterization of crystals 
Crystals grown on bulk surfaces and in microfluidic devices were isolated under an 
optical stereomicroscopy using fine tweezers or the sharp tip of an X-Acto blade. In most 
cases, the polymorphs of barbital could be identified and sorted based on the distinctive 
rod, block and plate morphologies exhibited consistently by forms I, II and IV, 
respectively. We found that form I of acetaminophen was the only polymorph that grew, 
and that form I was identified readily based on the distinctive block morphology. Crystals 
grown in microfluidic channels generally were smaller necessarily than those grown on 
bulk surfaces. Thus, it was more difficult to isolate and characterize crystals in 
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microchannels. Samples of individual crystals typically consisted of no more than 1 mg 
(typically less) of crystals regardless of the technique used. 
Crystals of forms I, II and IV of barbital and forms I and II of acetaminophen can be 
characterized using a variety of analytical techniques that include melting point, optical 
microscopy, IR spectroscopy, 13C CP/MAS NMR and X-ray powder diffraction. Each of 
these techniques is described in the sections that follow. Although X-ray powder 
diffraction and 13C CP/MAS NMR spectroscopy commonly are used to identify and 
distinguish polymorphs, both techniques require approximately 50-100 mg of sample 
achieve satisfactory signal-to-noise. Consequently, we utilized melting point, optical 
microscopy and infrared spectroscopy as the primary means to identify the polymorphs of 
barbital and acetaminophen. 
 
4.3.1 Melting point 
Pure, crystalline solids have a characteristic melting point, the temperature at which 
the solid melts to become a liquid. Each polymorph typically has a distinct melting point 
that differs from those of other polymorphs. The difference in magnitude between two 
melting points usually reflects the relative difference in lattice energies of two 
polymorphs with the more stable polymorph having the higher melting point. Thus, 
polymorphs with similar lattice energies may exhibit melting points that are close or even 
identical.160 Forms I, II and IV of barbital have melting points of 190 °C, 183 °C and 176 
°C, respectively, while forms I and II of acetaminophen have melting points of 171 °C 
and 160 °C. The relatively large differences make identification of the various 
polymorphs of barbital and acetaminophen straightforward using melting point. 
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4.3.2 Optical microscopy 
Optical microscopy provides a rapid and convenient method to screen the 
homogeneity of samples of crystals visually and to record digital images of samples for 
analysis and comparison. Polymorphs frequently grow with unique morphologies, or 
habits, that allow different crystalline forms to be distinguished. It is important to note, 
however, that many compounds may crystallize in a single packing arrangement that 
exhibits different habits depending on the conditions used for crystallization. Moreover, 
different polymorphic forms may exhibit similar habits. Therefore, observation of 
crystals with different habits does not always indicate the presence of polymorphs. When 
crystals with different habits form, analysis by another analytical technique generally is 
required. In the case of barbital, forms I, II and IV form distinct rod, prism and plate 
morphologies (Figure 4.4) that have been reported previously by Craven.65 
 
Form I Form II Form IV
  
Figure 4.4 Images of form I, II and IV of barbital. 
 
Similarly, forms I and II of acetaminophen exhibit block and prism morphologies 
(Figure 4.5) by which the forms can be distinguished visually.68,69,76 
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Form I Form II
 
Figure 4.5 Images of form I and II of acetaminophen.76 
 
Prior to removing crystals from bulk substrates and microchannels, images were 
taken of both bulk samples and individual crystals using a low-power optical 
stereomicroscope equipped with a digital camera. The images were then compared to 
those of the various polymorphs grown previously using normal methods of 
recrystallization of slow evaporation and rapid cooling of solutions in Pyrex beakers. 
 
4.3.3 Infrared Spectroscopy 
Infrared spectroscopy provides one of the more useful analytical methods to identify 
polymorphs. IR spectroscopy is particularly well suited to distinguish polymorphs of 
compounds that contain hydrogen-bonding functional groups. The stretching frequencies 
of hydrogen-bonding donors such as O-H and N-H groups and acceptors such as C=O 
groups vary significantly depending on type and number of hydrogen bonding 
interactions and differences in crystal packing. One advantage of IR over other  analytical 
techniques is that spectra can be collected on small amounts of sample using an 
attenuated total internal reflection (ATR) accessory. For example, most of the IR spectra 
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collected in this study were obtained from single crystals less than 1 mg in mass in order 
to unambiguously identify which polymorph was present. The three polymorphs of 
barbital can be distinguished readily by IR as reported previously by Craven.65 Shown in 
Figure 4.6 are the IR spectra of forms I, II and IV of barbital. 
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 Figure 4.6  (a) IR spectra for forms I, II and IV of barbital. (b) Expanded IR spectra of                               
zone 1. (c) Expanded IR spectra of zone 2. 
 
Forms I, II and IV of barbital were assigned to individual samples primarily based on 
characteristic differences in the N-H stretching absorptions in the range 3250-3050 cm-1 
and in the fingerprint region in the range 850-750 cm-1. Shown in Figure 4.7 are the IR 
spectra of forms I and II of acetaminophen. 
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Figure 4.7 (a) IR spectra for forms I and II of acetaminophen. (b) Expanded IR spectra of 
zone 1. (c) Expanded IR spectra of zone 2. (d) Expanded IR spectra of zone 3. 
 
Forms I and II of acetaminophen were assigned to samples primarily based on 
characteristic differences in the N-H and O-H stretching absorptions in the range 3350-
3000 cm-1 but also differences in the fingerprint region in the ranges 1400-1300 cm-1, 
1100-1000 cm-1, 850-800 cm-1 and 750-650 cm-1. The differences in the N-H and O-H 
stretching absorptions arise because of differences in the strengths of hydrogen bonds 
involving those groups.161 
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4.3.4 
13
C CP/MAS NMR 
13C cross-polarization/magic angle spinning (CP/MAS) NMR spectroscopy is an 
analytical method used with increasing frequency to investigate and characterize 
polymorphs.162,163 The 13C CP/MAS technique is sensitive to subtle differences in crystal 
packing, molecular conformations and hydrogen bonding in solids. For example, it has 
been shown that formation of a hydrogen bond to a carbonyl group generally causes the 
chemical shift of the carbonyl to move downfield by approximately 3 ppm.164 
Accordingly; we have used 13C CP/MAS NMR to characterize and identify the 
polymorphs of barbital. The 13C CP/MAS NMR spectra of forms I, II and IV of barbital 
are shown in Figure 4.8 and the corresponding chemical shift values for resonances for 
the three spectra are shown Table 4.3. 
 
  
Figure 4.8 13C CP/MAS NMR spectra of forms I, II and IV of barbital. 
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Table 4.3 Chemical shifts from 13C CP/MAS NMR spectra of forms I, II and IV of 
barbital. 
N N
O
OO
HH
2
4
5
6
77
88  
 
Atom Form I (ppm) Form II (ppm) Form IV (ppm) 
C(2) 152.8 148.0 149.2 
C(4) 176.1 178.1 180.0 
C(5) 58.8 58.8 58.1, 58.6 
C(6) 173.2 178.1 172.0 
C(7) 31.9, 35.0 33.3 32.1, 33.3 
C(8) 9.0, 9.8 10.0 9.3 
 
 
As shown in Figures 2.6, 2.7 and 2.8, the carbonyl group at C4 forms a hydrogen 
bond while the carbonyl group at C6 is not involved in hydrogen bonding. The 13C 
CP/MAS spectrum shows two separate resonances for C4 and C6 with the peak for C4 
shifted downfield by 3 ppm. The carbonyl group at C2 of form I, which also forms a 
hydrogen bond, is shifted downfield by 3 ppm when compared to the carbonyl group at 
C2 in the spectrum of form 2, which is not involved in hydrogen bonding. In the 
spectrum of form II, the carbonyl groups at C4 and C6 both form one hydrogen bond, and 
thus have identical chemical shift and give just one resonance. In the 13C CP/MAS 
spectrum of form IV, the resonances for C4 and C6 are separated by about 6 ppm (2 x 3 
pmm), reflecting the fact that the carbonyl group at C4 forms two hydrogen bonds, while 
the carbonyl group is not involved in hydrogen bonding. Comparison of the three spectra 
also reveals differences in the number and chemical shift values of resonances for C5, C7 
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and C8 that arise because the molecules adopt reside in different conformations and 
crystal packing arrangements in the three forms. 13C CP/MAS spectroscopy was not used 
to characterize forms I and II of acetaminophen. 
 
4.3.5. X-Ray Powder Diffraction 
X-ray powder diffraction (XPD) is the most widely used technique for identifying 
polymorphs.165-167 The XPD pattern from a crystalline solid results satisfying the Bragg 
equation, n? = 2d sin?, where n is an integer, ? is the wavelength of radiation, d is the 
spacing between parallel planes of electron density in the crystal lattice, and ? is the angle 
at which X-rays diffract.168 The different d spacings within a given unit cell give rise to 
diffraction peaks that are plotted as values of 2? along the x-axis in the XPD pattern. The 
2? values of the peaks reflect the different lattice spacings and thus the dimensions of the 
unit cell.  Thus, each polymorph generates a unique XPD pattern because the dimensions 
of the unit cells differ considerably. For example, shown in Figure 4.9 are the XPD traces 
for forms I, II and IV of barbital. Comparison of the XPD patterns reveals that each form 
gives rise to a XPD pattern with unique peaks that do not overlap with those of the other 
polymorphs.  
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Figure 4.9 X-ray powder diffraction traces of forms I, II and IV of barbital (a-c, 
respectively).  The dotted lines mark the positions of the more intense peaks in the trace 
of form I (a).  Overlap of these peaks with peaks in the trace of form IV (c) indicate 
contamination of form IV by approximately 5% of form I. 
 
4.4 Results and Discussion 
Crystallization using methods 1, 2 and 3 on bulk surfaces was carried out with 
barbital using ethanol, water and ethyl acetate as solvents, and with acetaminophen using 
just ethanol as the solvent. Crystallization in microfluidic channels was carried out with 
just barbtial using methods 1 and 2. The results of these experiments are presented below 
and are broken down hierarchically by drug, substrate (i.e., bulk surface or microfluidic 
channel), and solvent system used. 
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The crystallization behavior of acetaminophen and barbital in this study can be 
broadly summarized as follows. Crystals of form I for acetaminophen dominated the 
results from ethanolic solutions on all surfaces. For barbital, form IV unexpectedly 
dominated on many of the surfaces in all three solvent systems, but especially from 
ethanolic solutions. The different polymorphic forms of acetaminophen and barbital were 
identified primarily using optical microscopy and infrared spectroscopy. 
Forms I, II and IV of barbital exhibited distinct rod, prism and plate morphologies or 
habits, respectively, similar to those reported by Craven, as shown previously in Figures 
2.6, 2.7, 2.8 and 4.4.68,69 Shown in Figure 4.10 are representative examples of the 
morphologies, of forms I, II and IV of barbital that were collected from crystallization 
experiments on SAMs (Form I on SAM III, form II on SAM II, and form IV from SAM 
IV in a microchannel) in ethanolic solutions. Slight differences in morphology are 
evident when images of polymorphs grown on SAMs are compared to those grown from 
methanolic solution in a glass beaker. For example, form I grows as flattened rods or 
thick plates as shown on the left in Figure 4.10. This morphology differs from that 
normally observed (left in Figure 4.4) where the rods exhibit nearly uniform thickness 
that reflects the high symmetry (R-3) of the space group. Form II grows as elongated 
prisms with parallelogram or truncated parallelogram shapes. This morphology differs 
significantly from the block-like prisms shown in the center in Figure 4.4. The plate 
morphology of form IV grown on SAMs is similar to the plate morphology grown in 
glass beakers. 
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Figure 4.10 Forms I, II and IV of barbital from different substrates. 
 
Similarly, forms I and II of acetaminophen exhibit block and prism morphologies 
(Figure 4.5) by which the forms can be distinguished visually.76 Shown in Figure 4.11 are 
representative examples of forms I and II of acetaminophen from bulk surface 
experiments (both grown on SAM III). We found that form I grew as blocks (left in 
Figure 4.11) with morphology similar to that observed previously. In contrast, form II 
formed polycrystalline films (right in Figure 4.11) on SAMs in the few experiments 
where form II appeared instead of single crystals with the expected prism morphology. 
 
                           
Form I
1.5 mm 1.5 mm
Form II
 
Figure 4.11 Forms I and II of acetaminophen from different substrates. 
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Examples of crystal forms of acetaminophen and barbital grown on SAMs I-V and on 
control surfaces that are glass, gold and PDMS are shown for each drug with each 
solvent. The results of the experiments with acetaminophen are summarized and 
presented first, followed by the results of experiments with barbital. The experiments 
with barbital on bulk surfaces and microchannels are presented separately. Each section 
is divided in subsections according to the solvents used. 
 
4.4.1 Acetaminophen 
4.4.1.1 Bulk Surfaces 
4.4.1.1.1 Ethanol 
Acetaminophen crystallization experiments were done only in ethanol on SAMs I-V 
and also on gold and glass as control experiments. Form I (the common form) is more 
stable at room temperature than form II (but is not suitable commercially for direct 
compression into tablets74,75). Because of that SAMs with different polar and nonpolar 
head groups used to control the nucleation of acetaminophen to get the less common form 
II. Examples from each surface are shown in Figure 4.12. 
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 79
Figure 4.12 Examples of acetaminophen crystal pictures on each surface for each 
method. 
 
Characterization of crystals by optical microscopy and infrared spectroscopy, 
revealed that form I was the predominant polymorph of acetaminophen that formed on 
SAMs I-V and the control surfaces. The results of these experiments using all three 
methods are summarized in Figure 4.13. Form II appeared only in one out of five runs on 
SAMs I and IV, and in three out of five runs on SAM III when acetaminophen was 
crystallized using method 1. This selectivity for form I was even more pronounced for 
method 2, which gave only form I, and for method 3, which gave form II in one out of 
five runs on SAM II. In summary, form II appeared only six times out of a total of 105 
runs on different surfaces using methods 1-3. These results indicate that, at least for the 
surfaces and methods we utilized, the crystallization behavior of acetaminophen did not 
deviate from that normally observed in the absence of SAMs. Ultimately, we were not 
able to determine why acetaminophen crystallized predominantly as form I on SAMs I-V 
and the control surfaces. Although we can propose several explanations for this behavior, 
none can be substantiated without further investigation. For example, it is possible that 
the surfaces we examined do act as templates that promote aggregation of acetaminophen 
on the surface, and that all of the surfaces simply favor aggregates that nucleate form I 
preferentially instead of form II. Alternatively, nucleation may occur in solution on dust 
or other airborne contaminants. The fact that form II appeared in just 6 of 105 runs on 
SAMs or control surfaces was surprising, especially considering that Lang, Grzesiak and 
Matzger found that form II nucleated readily on a range of solid polymers.51 One 
 80
important difference between the two studies is that SAMs present essentially two-
dimensional surfaces that have lower interaction energy with molecules in solution than 
three-dimensional surfaces such as those presented on solids of polymers. Consequently, 
three-dimensional surfaces may be necessary to achieve high enough interaction energy 
for templating of form II of acetaminophen to occur. 
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Figure 4.13 Results of acetaminophen crystallization experiments for each method. 
 
After completing the crystallization experiments with acetaminophen in ethanol and 
finding no evidence of form II, we decided to stop experiments with acetaminophen and 
focus our efforts instead on crystallization experiments with barbital.  
 
4.4.2 Barbital 
4.4.2.1 Bulk surfaces   
4.4.2.1.1 Ethanol 
Examples of crystals grown from each different surface are shown in Figure 4.14. 
The results are summarized in Figure 4.15 as a graph for each method. 
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method 1             method 2         method 3 
Figure 4.14 Examples of barbital crystal pictures on each surface for each method from 
ethanolic solution. 
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Figure 4.15 Results of barbital crystallization experiments for each method from 
ethanolic solution. 
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The experiments on SAMs in ethanol clearly show that form IV of barbital was the 
dominant polymorph for methods 1 and 2 on SAMs I-V, with form IV appearing as the 
only polymorph on SAMs I and III by method 1 and on SAMs I, II and IV by method 2. 
Exceptions occurred on SAMs II and IV by method 1 and SAM IV by method 2. In those 
cases, form I or II appeared concomitantly with form IV in equal or slightly greater 
frequency. In contrast, form II appeared concomitantly with form IV on all SAMs by 
Method 3. In the control experiments, gold and glass substrates always gave mixtures of 
the three polymorphs concomitantly by methods 1-3 with the exception that form I did 
not appear on bare gold by method 3. These results show crystallization under 
thermodynamic conditions by methods 1 and 2 generally give greater selectivity for one 
form than crystallization under kinetic conditions by method 3. Moreover, the greater 
selectivity under thermodynamic conditions generally favors form IV over forms I and II 
on SAMs. This result is surprising considering that SAM IV is the least stable polymorph 
of the three forms of barbital. More surprising is the fact that form IV appears with 
approximately equal frequency on all SAMs. Although we anticipated that the different 
functional groups exposed on the surface of SAMs I-V would lead to selective nucleation 
of forms I, II and IV, we did not expect that nucleation of form IV would predominate on 
all SAMs. 
Plates of form IV grew consistently oriented on all SAMs with the large rectangular 
010 face in contact with SAMs. This behavior suggested that preferential orientation 
might occur because of favorable interaction between functional groups exposed on the 
010 face of the crystal and those on the surface of the SAM. Analysis of the crystal 
packing in the crystal structure of form IV revealed that the hydrogen-bonded layers of 
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molecules stack on top of one another along the 010 direction in the crystals. As shown in 
Figure 4.16, that packing arrangement exposes the polar hydrogen-bonding groups on 
individual molecules of barbital at the small facets presented on the edges of the plates 
and the nonpolar ethyl groups (colored magenta in Figure 4.16) at the surface of the large 
010 facet. Thus, the large 010 face on plates of form IV are hydrophobic. The fact that 
the hydrophobic 010 faces of crystals of form IV always contact the surface of SAMs I-V 
in ethanol suggests that hydrogen bonding is not involved in promoting oriented growth.  
Rather, we hypothesize that molecules of ethanol solvent bind to the surface of SAMs II-
V by forming strong hydrogen bonds to the OH, CO2H and pyridine groups, thereby 
creating ordered layers of solvent that generate a hydrophobic surface. This concept is 
illustrated in Figure 4.16. Alcohols are known to be good hydrogen-bonding donors and 
acceptors that generally form strong hydrogen bonds.169 As shown in Figure 4.16, 
aggregation of ethanol onto the surface via hydrogen bonding necessarily results in 
oriented assembly with the ethyl groups exposed at the surface. Ordered solvation in this 
manner would effectively block the hydrogen-bonding groups of the SAMs and present a 
hydrophobic surface of ethyl groups similar to that presented on the 010 face of crystals 
of form IV. In the absence of exposed hydrogen-bonding groups on the surface, 
templating of molecules onto the surface via hydrogen bonding should not occur. 
Moreover, the hydrogen-bonded layers in form IV maximize hydrogen-bonding contacts 
between molecules of barbital within layers while eliminating hydrogen bonding between 
adjacent layers and to surfaces. It follows that form IV should be favored in the presence 
of surfaces with no exposed hydrogen-bonding groups because hydrogen bonding is 
favored within layers. Conversely, forms I and II may be favored when in the presence of 
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surfaces with exposed hydrogen-bonding groups if hydrogen-bonded contacts between 
molecules of barbital and the surface are more energetically favorable than those between 
molecules of barbital. Accordingly, we hypothesize that oriented growth of form IV with 
the 010 face in contact with SAMs occurs as a result of maximizing favorable 
hydrophobic interactions between molecules of barbital in hydrogen-bonded layers and 
the solvated surface as layers form. Solvation of SAMs II-V by ethanol in this manner 
would give hydrophobic surfaces essentially similar to that of hydrophobic SAM I, and 
would explain why the crystallization behavior is similar on all five SAMs.  
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Figure 4.16 Top: Image of a crystal of form IV showing the large 010 face of the plate 
morphology in the plane of the page. Middle: View of a single hydrogen-bonded layer of 
barbital molecules view from the side showing the ethyl groups (magenta) exposed above 
and below the layer on the 010 surfaces. Bottom: Illustration showing how solvation of a 
carboxylic acid terminated SAM by an ordered layer of ethanol molecules could result in 
exposure of ethyl groups to create a hydrophobic surface. 
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4.4.2.1.2 Water 
We chose to investigate the crystallization behavior of barbital in water in order to 
test our hypothesis in the previous section that solvation of surfaces by ethanol minimizes 
or eliminates hydrogen bonding between barbital and the surface. We reasoned that 
hydrogen bonding of water to the OH, CO2H and pyridine headgroups of SAMs II-V 
should still present hydrophilic surfaces with exposed OH groups capable of hydrogen 
bonding to barbital and, thus, capable of templating aggregation of barbital on the 
surface. In contrast to the ethanol, the solubility of barbital in water was very low. In 
combination with the low volatility of water, the low solubility of barbital eliminated 
method 1 as a choice for growing crystals in a timely manner. Consequently, only 
methods 2 and 3 were utilized for growing crystals. Examples of crystals grown from 
each different surface are shown in Figure 4.17. The results are summarized in Figure 
4.18 as a graph for both methods. 
 
SAM I              SAM II 
     
method 2                   method 3          method 2                 method 3 
 
 
0.2 mm 0.2 mm 0.8 mm 0.5 mm 
 90
SAM III      SAM IV 
       
method 2           method 3                 method 2             method 3 
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Glass       PDMS 
     
method 2           method 3               method 2            method 3 
Figure 4.17 Examples of barbital crystal pictures on each surface for each method from 
water solution. 
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0.5 mm 1 mm 0.5 mm 1 mm 
0.5 mm 4.5 mm 0.3 mm 1 mm 
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Figure 4.18 Results of barbital crystallization experiments for each method from water 
solution. 
  
The experiments on SAMs in water show greater variability with slightly lower 
selectivity for form IV and a higher incidence of form I by both methods when compared 
to the results from ethanol. Forms I and IV both appeared concomitantly on SAMs I and 
III with form I predominating on SAM III by method 2. All three forms appeared 
concomitantly on SAMs II, IV and V by method 2. It is notable that form IV is the only 
polymorph to appear on the bare gold control surface because gold behaves as a 
hydrophobic surface. This result supports our hypothesis that hydrophobic surfaces 
promote nucleation of form IV. Even more notable is the fact that bare glass gave only 
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forms I and II in water by method 2. This data contrasts sharply with the experiments in 
ethanol where form IV predominated. This result supports our claim that hydrophilic 
surfaces with exposed OH groups can promote templating of forms I and II where the 
molecules bind to the surface via hydrogen bonding. Similar to experiments in ethanol, 
method 3 gave a much higher incidence of form II. In contrast to experiments in ethanol, 
however, method 3 did not appear to lower selectivity. For example, only two forms 
appeared on SAMs II and V by method 3, while all three forms appeared on SAMs I, III 
and IV by method 3. This level of selectivity is comparable to that observed by method 2. 
Although the ratio of forms II and IV by method 3 varied slightly from SAM to SAM in 
water compared to ethanol, the ratio of forms II and IV summed over all SAMs remained 
constant at 1:1 in both solvents by method 3. These results show that while crystallization 
under thermodynamic conditions in water still favors metastable form IV, it also gives a 
considerably higher incidence of form I, which is the most stable polymorph. Together, 
with the data from experiments in ethanol, these results also indicate that crystallization 
under kinetic conditions generally gives a higher incidence of form II than under 
thermodynamic conditions independent of the SAM that is used. Perhaps most 
importantly, the fact that form IV predominates only on hydrophobic SAM I supports our 
claim that templated nucleation via hydrogen bonding to surfaces can promote different 
polymorphs than those that appear on hydrophobic surfaces. 
It is worth noting that crystals of form IV frequently appeared oriented with the large 
rectangular 010 face in contact with SAMs. In a several cases, plates of form IV were 
observed growing on hydrophilic SAMs attached at the edge of the plate with the 010 
face orientated at an oblique angle to the plane of the surface. In that orientation, a plate 
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necessarily attached to the surface with the hydrogen-bonding groups of barbital at the 
edge of the plate in contact with the hydrogen-bonding groups on the surface of the SAM. 
These results suggest that hydrogen bonding plays a role in determining the orientation of 
crystals of barbital with respect to the surfaces. The fact that form IV appeared at all on 
hydrophilic SAMs indicates, however, that templated nucleation via hydrogen bonding of 
molecules on SAMs can lead to more than one polymorph.  
   
4.4.2.1.3 Ethyl Acetate 
In addition to ethanol and water, we chose investigate the crystallization behavior of 
barbital in ethyl acetate to examine the influence of a polar aprotic solvent with no acidic 
hydrogen-bonding donors on the crystallization behavior of barbital. We also wanted to 
further test our hypothesis that solvation of surfaces inhibits hydrogen bonding between 
barbital and the surface. We expected that a hydrogen bonding might still occur between 
ethyl acetate and the OH and CO2H groups on SAMs II-V because they contain acidic 
donors capable of bonding to the carbony oxygen acceptors on ethyl acetate. Considering 
that the carbonyl groups of esters usually are weak acceptors compared to hydroxyl 
groups, we expected solvation of SAMs, if it occurred at all, to form weak intermolecular 
contacts that resulted in poor coverage. Examples of crystals grown on each different 
surface are shown in Figure 4.19. The results are summarized in Figure 4.20 as a graph 
for the three crystallization methods. 
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Figure 4.19 Examples of barbital crystal pictures on each surface for each method from 
ethyl acetate solution. 
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Figure 4.20 Results of barbital crystallization experiments for each method from ethyl 
acetate solution. 
 
The experiments in ethyl acetate also show greater variability with slightly lower 
selectivity for form IV and a higher incidence of forms I and II when compared to the 
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results form ethanol. Forms I, II and IV appeared concomitantly on SAMs I, II, IV and V 
with form IV appearing most frequently by method 1. Overall, the results from method 1 
on SAMs in ethyl acetate were similar to those obtained in water from using method 2. 
Method 2 showed greater selectivity for form IV, which predominated on SAMs I-III. 
Form II was the only polymorphs to appear on SAM V by method 2, which interestingly 
was the only set of conditions that produced form II in the absence of other polymorphs. 
It should be noted that form I predominated on SAM I by method 1 and was the only 
polymorph by method 2. These results are consistent with the results in ethanol and 
water, and provide further evidence that hydrophobic surfaces favor nucleation of form 
IV under thermodynamic conditions. The results of crystallization by method 3 in ethyl 
acetate deviate significantly from those in ethanol and water. Method 3 clearly favored 
form IV on all SAMs with form IV appearing exclusively on SAMs II and III, 
concomitantly with forms I and II on SAMs IV and V, respectively, and concomitantly 
with both forms I and II on SAM I.  
 
4.4.2.2 Microfluidic Device 
Crystallization experiments with barbital were carried out on SAMs I-V in 
microfluidic channels in addition to SAMs on bulk surfaces in an effort to develop 
methods for high throughput crystallization on surfaces. These experiments different 
necessarily from those on bulk surfaces in that evaporation by methods 1 and 2 were not 
possible. Instead, crystallization was carried out as described earlier by allowing 
solutions of barbital to sit over SAMs in microchannels either at room temperature 
(method 2) or by rapidly cooling of more concentrated solutions (method 3). Experiments 
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in microchannels were carried on in ethanol and water. Ethyl acetate could not be used 
because it caused PDMS in the walls of the microchannels to swell. One of the goals of 
these experiments was to determine if polymorphs nucleated on SAMs in microchannels 
had the same habit as those nucleated on bulk surfaces. We found that the habits of the 
different polymorphs in microfluidic channels remained consistent with those observed 
on SAMs on bulk surfaces. We also aimed to determine if PDMS in the walls of the 
microchannels influenced nucleation crystals in competition with SAMs. Plates of form 
IV in particular generally grew oriented with the large rectangular 010 face in contact 
with SAMs as observed earlier on bulk surfaces. The high frequency with which crystals 
of form IV grew in this manner indicates that oriented growth on the underlying SAM 
probably occurs during nucleation. Crystals often first appeared at the edges of channels. 
Models for heterogeneous nucleation and growth of molecular crystals have established 
that molecular aggregation from solution is most favorable at high energy surfaces at 
kink sites (corners) and step edges.170 Therefore; it was not surprising to find crystals of 
barbital often appearing at the edges of channels where SAMs come into contact with 
PDMS. Even though repeated attempts were made to observe under the microscope the 
location if initial growth, it was not possible to discern whether nucleation occurred 
selectively on SAMs or on PDMS. In all cases, crystals appeared to form at the interface 
between the two.  
 
4.4.2.2.1 Ethanol 
Examples of crystals grown on each different surface are shown in Figure 4.21. 
Shown in Figure 4.22 are the distributions of forms I, II and IV of barbital that grew from 
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ethanolic solutions in microchannels over SAMs I-V and PDMS under thermodynamic 
conditions (method 1) and kinetic conditions (method 2). Also shown for comparison are 
the distributions of polymorphs that appeared on bulk gold, glass and PDMS substrates in 
the absence of microchannels.  
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Figure 4.21 Examples of barbital crystal pictures in microchannels from ethanolic 
solution. 
 
Shown in Figure 4.22 are the distributions of forms I, II and IV of barbital that grew 
in microchannels over SAMs I-V and PDMS under thermodynamic conditions (method 
1) and kinetic conditions (method 2). Also shown for comparison are the distributions of 
polymorphs that appeared on bulk gold, glass and PDMS substrates in the absence of 
microchannels. 
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Figure 4.22 Results of barbital crystallization experiments in microchannels from 
ethanolic solution. The distribution of forms I, II and IV that grew on bulk Au, glass and 
PDMS substrates are shown for comparison. 
 
Form IV of barbital clearly was the dominant polymorph regardless of the substrate 
and crystallization method used with ethanol. For ethanolic solution under 
thermodynamic conditions (method 1), form IV was the only polymorph that appeared in 
microchannels. This result was unexpected for the following reasons: (1) form IV 
generally is the most difficult polymorph to prepare by conventional methods of 
crystallization from solution, (2) form IV is the least stable of the three polymorphs, and 
(3) concomitant crystallization of all three forms from bulk ethanolic solutions usually 
favors forms I and II. For example, all three polymorphic forms appear when barbital is 
crystallized over bare gold and glass substrates, as shown in Figure 4.22. Even more 
surprising was the lack of variation in selectivity across the range of different functional 
groups presented at the surface of SAMs I-V. These results differ slightly from those on 
SAMs on bulk surfaces where form IV predominated in ethanol, but did not always form 
exclusively. It is noteworthy that form IV was the only polymorph observed in 
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microfluidic channels under thermodynamic conditions with PDMS as the substrate. 
Form IV also was the only polymorph observed in the absence of microchannels when 
barbital was crystallized by slow evaporation of ethanolic solutions over bulk PDMS 
substrates. These results suggest that PDMS probably plays a significant role in 
promoting nucleation of form IV, and that the influence of PDMS likely is as important 
(if not more important) than that of SAMs under thermodynamic conditions. 
Crystallization of barbital under kinetic conditions (method 2) on SAMs also showed 
high selectivity for form IV. For example, Figure 4.22 shows that form IV appeared 
exclusively in microchannels over SAMs I-IV, while all three forms appeared in 
microchannels over SAM V. The high selectivity for the least stable polymorph in the 
presence of SAMs again was surprising, especially considering that kinetic conditions 
often lower selectivity and promote formation of multiple polymorphic forms. A decrease 
in selectivity in fact was observed for method 2 compared to method 1 on bulk gold, 
glass and PDMS surfaces as well as in microchannels over PDMS. 
 
4.4.2.2.2 Water 
Examples of crystals grown from aqueous solutions on each different surface are 
shown in Figure 4.23.  Shown in Figure 4.24 are the distributions of forms I, II and IV of 
barbital that grew in microchannels over SAMs I-V and PDMS under thermodynamic 
conditions (method 1) and kinetic conditions (method 2). Also shown for comparison are 
the distributions of polymorphs that appeared on bulk gold, glass and PDMS substrates in 
the absence of microchannels. 
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Figure 4.23 Examples of barbital crystal pictures in microchannels from water solution. 
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Figure 4.24 Results of barbital crystallization experiments in microchannels from water 
solution. The distribution of forms I, II and IV that grew on bulk Au, glass and PDMS 
substrates are shown for comparison. 
 
The results from crystallizing barbital on SAMs in microfluidic channels from water 
differ from those from ethanol. Whereas form IV was the only polymorph that 
crystallized from ethanol by method 2, crystallization from water gave approximately 
equal amounts of forms II and IV concomitantly on SAMs I, III, IV and V. SAM II was 
the only surface that gave form IV exclusively in water by method 2. Notably, form IV 
appeared in all experiments on the PDMS control surface with form I appearing 
concomitantly in 3 of 5 experiments by method 1. Interestingly, form I of barbital 
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appeared only in the PDMS control experiments in microchannels by method 1. 
Crystallization by method 3 gave form IV exclusively on SAM IV, forms II and IV 
concomitantly on SAMs I-III, and all three forms on SAM V. Overall, forms II and IV 
predominated with form IV appearing with slightly higher frequency than form II.  
 
4.5 Conclusions 
We have demonstrated that SAMs appear to exert little or no influence over the 
nucleation and growth of forms I and II of acetaminophen from ethanol on bulk surfaces. 
In contrast, we found that SAMs clearly influence the nucleation and growth of 
polymorphic forms I, II and IV of barbital both on bulk surfaces and in microfluidic 
channels. Crystallization of barbital over SAMs in general showed a high selectivity for 
form IV, which is surprising because form IV is the least stable of the three polymorphs. 
This finding differs from the normally observed crystallization behavior of barbital on 
glass substrates where all three polymorphs crystallize concomitantly with forms I and II 
dominating. Surprisingly, the selectivity for form IV persists across the series of SAMs 
despite differences in the hydrophobic and hydrophilic head groups. An important finding 
of this study was that crystallization under thermodynamic conditions of slow 
evaporation generally resulted in greater selectivity for one or more forms of barbital 
when compared to crystallization under kinetic conditions by rapid cooling. Another 
unexpected result was that solvation of SAMs by polar solvents such as ethanol appears 
to render hydrophilic surfaces more hydrophobic, thereby favoring oriented nucleation of 
form IV of barbital. This finding is significant in that it shows that solvents likely play a 
significant role in promoting or inhibiting templating of molecules on surfaces through 
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hydrogen-bonding interactions, and thus in controlling nucleation of one polymorph over 
another. Although we were not able to control selectivity between forms I, II and IV of 
barbital exclusively based on the choice of SAMs, we showed that crystallization of 
barbital on bulk surfaces and in microchannels over SAMs provides a way to prepare the 
least stable polymorph reproducibly and that crystallization under thermodynamic 
conditions leads to greater selectivity. These studies also provide evidence that PDMS in 
the walls of the microchannels may influence nucleation of barbital to a greater extend 
than SAMs.  
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